New 24-Hour Wearable Drug Pump Revolutionizes Parkinson’s Disease Treatment
The NHS is set to offer a 24-hour wearable drug pump as a breakthrough in Parkinson’s disease treatment, providing round-the-clock medication and eliminating the need for multiple daily tablets. This innovative technology administers an infusion known as foslevodopa-foscarbidopa through a cannula under the skin, converting the drug into dopamine to aid in motor function and movement control. With the potential to transform the lives of patients who are no longer responsive to oral medication, the introduction of this technology has been described as ‘great news’ by NHS England’s medical director for specialised services. The therapy is expected to offer a new treatment option for nearly a thousand patients and significantly improve the quality of life for individuals living with Parkinson’s disease in the UK.
Prevalence of Parkinson’s Disease Expected to Rise to 12-17 Million by 2040
The prevalence of Parkinson’s disease is on the rise, with an estimated 12 million to 17 million people expected to be affected by 2040, according to a recent three-paper series in The Lancet. The series addresses the current state of…
Obesity Drugs’ Superpower: Taming Inflammation
Obesity drugs have another superpower: taming inflammation The latest generation of anti-obesity drugs has taken the world by storm, thanks to their effectiveness at treating diabetes and reducing weight. But these drugs also have a less well-known superpower: the ability…
New Electronic Device Developed to Correct Walking Disorders in Advanced Parkinson’s Disease
Neuroscientists and neurosurgeons at the universities of Bordeaux, France, and Lausanne, Switzerland, together with the Swiss Federal Institute of Technology, have made a groundbreaking discovery in the field of Parkinson’s disease. They have developed an electronic device aimed at correcting…
New Magnetogenetics Technique Shows Promise in Treating Parkinson’s Disease
Researchers have made a significant breakthrough in the treatment of Parkinson’s disease using a new technique called magnetogenetics. This innovative approach involves using very small magnets to wirelessly trigger specific, gene-edited nerve cells in the brain, effectively relieving motor symptoms…
New Study Shows Wearable Robotic Technology Offers Hope for Parkinson’s Disease Patients
Recent breakthroughs in medical technology have brought hope to individuals suffering from Parkinson’s disease. A new study published in Nature Medicine on 15th January 2024 reported a remarkable development in assisting a person with Parkinson’s disease to overcome freezing of…
Magnetogenetics: A Groundbreaking Treatment for Parkinson’s Disease
Researchers have made a groundbreaking discovery in the treatment of Parkinson’s disease using magnetized neurons. A team of scientists has reported in Nano Letters about a new technique called magnetogenetics, which uses tiny magnets to wirelessly stimulate specific gene-edited nerve…
New Approach to Targeting Parkinson’s Disease Protein Shows Promise in Research Study
Parkinson’s disease is a debilitating condition that can be caused by elevated levels of the intrinsically disordered protein α-synuclein, which lacks typical small-molecule binding pockets. However, a recent research article published in the field of applied biological sciences presents a…
Comprehensive Analysis Confirms Five Key Parkinson’s Disease Variants
A recent study published in Npj Parkinson’s Disease has conducted a comprehensive analysis of rare Parkinson’s disease (PD) variants in a large-scale cohort, confirming the existence of five key PD variants. This landmark study sheds light on the genetic factors…
Naturally Occurring Variant of SHLP2 May Offer Protection Against Parkinson’s Disease, Study Finds
Researchers have identified a naturally occurring variant of SHLP2 that may offer protection against Parkinson’s disease (PD). The study, published in Molecular Psychiatry, delves into the functional role of a mitochondrial DNA single nucleotide polymorphism (mtSNP) associated with reduced PD…